← All companies

ZIVO

ZIVO Bioscience, Inc.

ZIVO OTC Biological Products, (No Diagnostic Substances) EDGAR ↗

$4.00

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$15.6M

Revenue (TTM)

$209K

Net income (TTM)

-$8.49M

EPS (TTM)

$-2.13

P/E ratio

—

Dividend yield

77.75%

Free cash flow

—

Cash

$57.2K

Total assets

$559K

Gross margin

31.7%

52-week range

$1.11 – $19.65

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Regulation FD disclosure Mar 30, 2026 8-K Director or officer change Dec 23, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Regulation FD disclosure Sep 10, 2025 8-K Director or officer change Aug 18, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jul 14, 2025 8-K Shareholder vote results Jun 11, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-K Fiscal year ended 2024-12-31 Mar 18, 2025 8-K Unregistered sale of equity Jan 27, 2025 8-K Entered a material agreement Jan 15, 2025 8-K Other events Jan 7, 2025 8-K Entered a material agreement; Took on a direct financial obligation Nov 15, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Unregistered sale of equity Oct 18, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Director or officer change Jul 17, 2024 8-K Shareholder vote results Jun 13, 2024 8-K/A Entered a material agreement Jun 7, 2024 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change Jun 6, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 10-K Fiscal year ended 2023-12-31 Mar 15, 2024 8-K Delisting notice or listing-rule failure Feb 15, 2024 8-K Unregistered sale of equity Jan 17, 2024 8-K Unregistered sale of equity Jan 5, 2024 8-K Unregistered sale of equity Jan 3, 2024 8-K Unregistered sale of equity Dec 11, 2023 8-K Delisting notice or listing-rule failure Nov 27, 2023 8-K Entered a material agreement; Took on a direct financial obligation Nov 22, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Modified rights of security holders; Amended charter or bylaws Oct 26, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Delisting notice or listing-rule failure Aug 9, 2023 8-K Entered a material agreement; Unregistered sale of equity Jul 6, 2023 8-K Shareholder vote results Jun 16, 2023 8-K Delisting notice or listing-rule failure May 26, 2023 10-Q Quarter ended 2023-03-31 May 10, 2023 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Apr 5, 2023 10-K Fiscal year ended 2022-12-31 Mar 14, 2023